The International Symposium on Merkel cell carcinoma is scheduled for October 21-22, 2019 at the Moffitt Cancer Center in Tampa, Florida.
Course Directors: Kenneth Y. Tsai MD, PhD and Vernon K. Sondak, MD
Course Description: The International Symposium on Merkel cell carcinoma is a first-of-its-kind educational program of thought leaders and active investigators in Merkel cell carcinoma (MCC) brought together for the purpose of promoting scientific discourse and collaboration toward the goal of improved understanding of MCC biology, pathogenesis, and therapy. The areas of focus will span the entire range of basic science to translational studies to clinical trials. The format will include several sessions with talks and abstract presentations emphasizing new, unpublished work throughout the two-day symposium. Roundtable discussions will be centered on pressing questions in the field including how best to address the role of radiation therapy, immunotherapy resistance, and the future of molecularly-targeted and orthogonal immunotherapeutic approaches.
Abstract submissions will be accepted until May 31st, 2019.
Target Audience: This program is designed for oncologists, dermatologists, pathologists, and other healcare professionals and scientists interested in Merkel cell carcinoma.
To view updates and conference details visit: Moffitt.org/MerkelSymposiumView the Brochure
The authoritative source on Merkel cell carcinoma.
May 20, 2020
- What is a Merkel cell?
- What is Merkel cell carcinoma?
- Symptoms & appearance of Merkel cell carcinoma
- Causes of Merkel cell carcinoma
- Surgical excision
- Mohs micrographic surgery
- Radiation therapy
- Complementary & alternative therapies
- Clinical trials
- Adjuvant Avelumab in Merkel Cell Carcinoma Trial